Ng George K
SEC CIK 1638744 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | CEO, Dir | 17.1K | $151.8K | — | 15 | 2023-10-10 | 2026-08-08 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-11 16:21 | 2026-08-08 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | M - OptEx | — | +1,600 | 17.1K | +10% | — |
| 2026-07-01 16:19 | 2026-07-01 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $1.93 | +3,057 | 15.5K | +25% | +$5,900 | |
| 2026-06-16 16:22 | 2026-06-15 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.22 | +2,465 | 12.4K | +25% | +$5,472 | |
| 2026-06-01 16:58 | 2026-05-29 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.57 | +2,129 | 9,970 | +27% | +$5,472 | |
| 2026-05-19 18:06 | 2026-05-15 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.97 | +1,843 | 7,841 | +31% | +$5,474 | |
| A | 2026-05-19 17:31 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.97 | +1,843 | 3,979 | +86% | +$5,474 |
| 2026-05-01 16:37 | 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.69 | +2,034 | 6,013 | +51% | +$5,471 | |
| A | 2026-04-30 16:33 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.97 | +1,843 | 3,979 | +86% | +$5,474 |
| A | 2026-04-30 16:32 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.54 | +2,136 | 2,136 | New | +$5,415 |
| 2026-04-17 16:54 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.97 | +1,843 | 5,492 | +51% | +$5,474 | |
| 2026-04-01 17:15 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.54 | +2,136 | 3,649 | +141% | +$5,415 | |
| I | 2025-01-29 | 2025-01-27 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $0.8 | +87.2K | 87.2K | New | +$69.8K |
| I | 2024-01-31 | 2024-01-30 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | P - Purchase | $2.70 | +10.0K | 20.0K | +100% | +$27.0K |
| 2023-10-12 | 2023-10-12 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | A - Grant | $0.25 | +100.0K | 200.0K | +100% | +$25.0K | |
| 2023-10-10 | 2023-10-10 | PCSA | Processa Pharmaceuticals, Inc. | Ng George K | CEO, Dir | A - Grant | $0.25 | +100.0K | 100.0K | New | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations